IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.32) per share. This is a 100 percent decrease over losses of $(0.66) per share from the same period last year.
Revolution Medicines Q2 EPS $(0.82) Beats $(0.84) Estimate, Sales $9.12M Beat $7.02M Estimate
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(0.84) by 2.38 percent. This is a 36.67 percent decrease over losses of $(0.60) per share
